Chapter 18 - Eye And Ear Medications Flashcards
Terminology
Anti-infective ophthalmic topical ointments and solutions
P. 321-322
Are available for the treatment of superficial infections of the eye caused by susceptible organisms.
• Medication used in the treatment of infections; includes antibiotics, antifungals, and antivirals.
Anti-inflammatory ophthalmic agents (Corticosteroids)
P. 323
Are used to relieve inflammation of the eye or conjunctiva in allergic reactions, burns, irritation from foreign substances or post-operatively.
Nonsteroidal Anti-inflammatory ophthalmic drops (NSAIDS)
P. 324
Are used to treat post-operative inflammation following cataract surgery.
Ophthalmic Immunologic Agent
P. 324
(e.g. topical cyclosporine [Restasis])
Increases shoe production in patients with tear production is presumed to be suppressed due to ocular inflammation. It is an immunosuppressive agent for organ transplant rejection prophylaxis when administered systemically.
Ophthalmic antihistamines or decongestants
P. 325
Blocks histamine receptors in the conjunctiva, relieving ocular pruritis associated allergic conjunctivitis. Ophthalmic administration of decongestants causes vasoconstriction of blood vessels, thereby providing relief for minor eye irritation and redness.
Ophthalmic lubricants
P. 325
Ocular lubricant such as artificial tears solution provide a barrier function at the level of the conjunctival mucosa. They help dilute and plus various allergens and inflammatory mediators that may be present on the ocular surface. Artificial tear products that contain preservatives may cause allergic reactions and should be stopped immediately.
Glaucoma
P. 326
Abnormal condition of the eye with increased intraocular pressure (IOP) because of obstruction of the outflow of aqueous humor.
• this causes deterioration of and damage to the optic nerve (which carries images on the retina to the brain), resulting in vision loss.
Acute (angle-closure) glaucoma
P. 326
Characterized by a sudden onset of pain, blurred vision, and a dilated pupil, this condition is considered a medical emergency. Although uncommon, if left untreated, blindness can result in a few hours or days.
Chronic (open-angle) glaucoma
P. 326
Much more common and often bilateral, this condition develops slowly over a period of years with few symptoms except a gradual loss of peripheral vision and possibly blurred vision. Halos around lights and central blindness are late manifestations.
The first step in glaucoma therapy is ____________________.
P. 326
Early diagnosis via screening and ensuring the patient abstains from medications that may exacerbate glaucoma.
Antiglaucoma drugs
P. 326
Given to lower intraocular pressure.
The five main categories of Antiglaucoma drugs:
P. 326-327
- Carbonic anhydrase Inhibitors, for example dorzolamide (Trusopt). Act by decreasing the formation of aqueous humor and have a diuretic effect.
- Miotics, for example pilocarpine. Act by increasing the aqueous humor outflow.
- Beta-adrenergic Blockers, for example timolol (Timoptic). Act be decreasing the rate of aqueous humor production.
- Alpha-agonists, for example brimonidine (Alphagan-P). Decrease the production of aqueous humor and increase outflow.
- Prostaglandin analogs, for example latanoprost (Xalatan). Act by increasing aqueous outflow.
Intraocular pressure
P. 326
Pressure within the eyeball.
Carbonic Anhydrase Inhibitors (CAIs)
P. 327
Such as acetazolamide reduce the formation of hydrogen and bicarbonate ions, which have a diuretic effect and reduce the production of aqueous humor.
Miotics, direct-acting
P. 328
Are medications that cause the pupil to contract. Miotics reduce IOP by increasing the aqueous humor outflow. The act by contracting the ciliary muscle; this mechanism also leads to blurred vision.